Authors:
Ripamonti, D
Massari, M
Arici, C
Gabbi, E
Farina, C
Brini, M
Capatti, C
Suter, F
Citation: D. Ripamonti et al., African sleeping sickness in tourists returning from Tanzania: The first 2Italian cases from a small outbreak among European travelers, CLIN INF D, 34(1), 2002, pp. E18-E22
Citation: C. Arici et al., Bis{(mu-acetato)(N,N '-dimethylformamide)[mu-bis(salicyl-idene)-1,3-propanediaminato]nickel(II)}copper(II), ACT CRYST E, 57, 2001, pp. m283-m285
Authors:
Svoboda, I
Arici, C
Nazir, H
Durmus, Z
Atakol, O
Fuess, H
Citation: I. Svoboda et al., {[mu-N,N '-Bis(salicylidene)-2,2 '-dimethyl-1,3-propanediamine](piperidine)copper(II)}dibromozinc(II), ACT CRYST E, 57, 2001, pp. M584-M586
Authors:
Simsek, N
Arici, C
McKee, ML
Ulku, D
Balci, M
Citation: N. Simsek et al., High-temperature bromination XIII: Bromination of dimethyl 7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate, STRUCT CHEM, 12(3-4), 2001, pp. 305-311
Authors:
Arici, C
Ripamonti, D
Ravasio, V
Maggiolo, F
Rizzi, M
Finazzi, MG
Suter, F
Citation: C. Arici et al., Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution, INT J STD A, 12(9), 2001, pp. 573-581
Authors:
Arici, C
Tebaldi, A
Quinzan, GP
Maggiolo, F
Ripamonti, D
Suter, F
Citation: C. Arici et al., Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART, INT J STD A, 12(6), 2001, pp. 407-409
Authors:
Kenar, A
Arici, C
Aksu, ML
Tahir, MN
Durmus, S
Atakol, O
Citation: A. Kenar et al., Crystal structure of {bis[N-(2-hydroxyethylamino)ethylsalicylaldiminato]-iron(III)} chloride, ANAL SCI, 17(4), 2001, pp. 569-570
Authors:
Nazir, H
Arici, C
Svoboda, I
Duzgun, E
Atakol, O
Fuess, H
Citation: H. Nazir et al., Crystal structure of bis{N,N'-dimethylformamide) (mu-acetato)[mu(N,N'-bis(salicylidene)-2-hydroxy-1,3-propanediamine] nickel(II)} cadmium(II), MAIN GR MET, 24(5), 2001, pp. 313-314
Authors:
Yalcin, N
Kenar, A
Arici, C
Atakol, O
Tastekin, M
Citation: N. Yalcin et al., The crystal structure of a dimeric complex formed between boric acid and N-2-hydroxyphenylsalicylaldimin, MAIN GR MET, 24(4), 2001, pp. 247-248
Authors:
Arici, C
Sari, M
Atakol, O
Fuess, H
Svoboda, I
Citation: C. Arici et al., Crystal structure of bis-{(mu-acetato)[mu-N,N '-bis(salicylidene)-2,2 '-dimethyl-1,3-propanediaminato]zinc(II)} zinc(II), MAIN GR MET, 24(4), 2001, pp. 255-256
Authors:
Atakol, O
Nazir, H
Arici, C
Svoboda, I
Fuess, H
Citation: O. Atakol et al., Crystal structure of bis{(N,N'-dimethylformamide) (mu-acetato)[mu-(N,N'-bis(salicylidene)-2-hydroxy-1,3-propanediamine] nickel(II)} zinc(II), MAIN GR MET, 24(2), 2001, pp. 125-126
Authors:
Boz, A
Arici, C
Gungor, F
Yildiz, A
Colak, T
Karayalcin, B
Citation: A. Boz et al., Gamma probe-guided resection and scanning with Tc-99m MIBI of a local recurrence of follicular thyroid carcinoma, CLIN NUCL M, 26(10), 2001, pp. 820-822
Citation: C. Arici et al., [N,N '-Bis(salicylidene)-2,2-dimethyl-1,3-propanediaminato]nickel(II) and [N,N '-bis(salicylidene)-2,2-dimethyl-1,3-propanediaminato]copper(II), ACT CRYST C, 57, 2001, pp. 812-814
Authors:
Arici, C
Svoboda, I
Sari, M
Atakol, O
Fuess, H
Citation: C. Arici et al., {Bis(N,N-dimethylformamide)[mu-N,N '-bis(salicylidene)-1,3-propane-diaminato]nickel(II)}dibromozinc(II), ACT CRYST C, 57, 2001, pp. 31-32
Authors:
Ozdemir, I
Yigit, B
Cetinkaya, B
Ulku, D
Tahir, MN
Arici, C
Citation: I. Ozdemir et al., Synthesis of a water-soluble carbene complex and its use as catalyst for the synthesis of 2,3-dimethylfuran, J ORGMET CH, 633(1-2), 2001, pp. 27-32
Citation: E. Kebebew et al., Localization and reoperation results for persistent and recurrent parathyroid carcinoma, ARCH SURG, 136(8), 2001, pp. 878-883
Authors:
Ingec, SK
Aydin, A
Soylu, H
Arici, C
Cakir, B
Sahin, MF
Citation: Sk. Ingec et al., Crystal structure of 1-[2(3H)-benzothiazolone-3-yl]propanoyl-morpholine, C14H16N2O3S, Z KRIST-NEW, 215(3), 2000, pp. 431-432
Authors:
Atakol, O
Durmus, S
Arici, C
Svoboda, I
Fuess, H
Citation: O. Atakol et al., Crystal structure of {[mu-N,N '-bis(salicylidene)-2,2 '-dimethyl-1,3-propanediamine](piperidine)copper(II)} dichlorozinc(II), MAIN GR MET, 23(12), 2000, pp. 791-792
Authors:
Pezzotti, P
Monforte, AD
Bugarini, R
Rezza, G
Arici, C
Angarano, G
Borderi, M
Alberici, F
Armignacco, O
Menichetti, F
Prestileo, T
Sighinolfi, L
Sinicco, A
Resta, F
Vigevani, M
Ippolito, G
Citation: P. Pezzotti et al., Antiretroviral therapy in HIV-infected individuals in clinical practice: Are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values?, EUR J EPID, 16(10), 2000, pp. 919-926
Authors:
Coskun, N
Tat, FT
Guven, OO
Ulku, D
Arici, C
Citation: N. Coskun et al., The first examples of di- and cis triaryl-3a,4,5,6-tetrahydroimidazo[1,5-b]isoxazoles and their ring-opening reactions, TETRAHEDR L, 41(28), 2000, pp. 5407-5409
Authors:
Aydin, A
Soylu, H
Akkurt, M
Arici, C
Erdemir, M
Citation: A. Aydin et al., Redetermination of the crystal structure of 2-(o-hydroxyphenyl)-Delta(2)-1,3-benzo[4,5]thiazoline, C13H9NOS, Z KRIST-NEW, 214(4), 1999, pp. 529-530